Taken together, these results further provide evidence of the anti-cancer properties of lapatinib and suggest a possible mechanism of action for the long-lasting effects that we demonstrated with short-term exposure to lapatinib in MMTV-erbB-2 mice. The gene discussed is EGFR; the disease is cancer.